We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
33 hedge funds and large institutions have $11.5M invested in Arcturus Therapeutics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.23% less ownership
Funds ownership: 8.44% → 5.21% (-3.2%)
21% less funds holding
Funds holding: 42 → 33 (-9)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
40% less call options, than puts
Call options by funds: $39K | Put options by funds: $65K
66% less capital invested
Capital invested by funds: $34.2M → $11.5M (-$22.7M)
Holders
33
Holders Change
-9
Holders Change %
-21.43%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
7
Reduced
9
Closed
18
Calls
$39K
Puts
$65K
Net Calls
-$26K
Net Calls Change
-$610K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$606K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$265K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$247K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$235K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$132K |
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$4.91M |
| 2 |
VMI
VHCP Management II
New York
|
-$1.79M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.71M |
| 4 |
BC
Broadfin Capital
New York
|
-$1.11M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.05M |
